Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
about
Terlipressin for hepatorenal syndromeTerlipressin for hepatorenal syndromeHepatorenal syndromeHuman albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansionAcute Kidney Injury in Patients with CirrhosisRenal failure in cirrhosis: Emerging conceptsCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisHuman albumin in the management of complications of liver cirrhosisAlbumin for end-stage liver diseaseTreatment and management of ascites and hepatorenal syndrome: an updateEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressProtecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study.Which patients benefit from hemodialysis therapy in hepatorenal syndrome?MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome.Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.Management of cirrhotic ascitesCurrent management of the complications of portal hypertension: variceal bleeding and ascites.Therapy insight: Management of hepatorenal syndrome.Management strategies in alcoholic liver disease.Drug insight: the role of albumin in the management of chronic liver disease.Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.What's new in the treatment of ascites and spontaneous bacterial peritonitis.Role of human albumin in the management of complications of liver cirrhosis.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.The role of the Molecular Adsorbents Recirculating System (MARS) in the management of liver failure.Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?Review article: prognosis of hepatorenal syndrome--has it changed with current practice?Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.Review article: pharmacological treatment of hepatorenal syndrome.Revision and update on clinical practice guideline for liver cirrhosis.Vasopressin and terlipressin: pharmacology and its clinical relevance.Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension.Hepatorenal syndrome: a dreaded complication of end-stage liver disease.Improving survival in decompensated cirrhosisReview article: current management of renal dysfunction in the cirrhotic patient.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.The aetiology, management and complications of alcoholic hepatitis.
P2860
Q24243962-402F70A4-B94E-4DD6-B852-8CEBD887962FQ24245600-F1D1E27E-D8D6-429C-A793-B9743F67F8E4Q24682192-DE133703-CD10-4891-B903-72BABE472245Q26765249-E7587BDD-F4DF-42C3-AC14-32FCE2F101D4Q26775643-486DC707-60FD-4079-B016-82808FCB2F1BQ26785971-18DFA113-C7C6-43E3-AA38-B4A96A1B9D47Q26795734-71217D7E-E2DF-41C0-906B-6FF5FCBC154FQ26852608-FE88AC7C-EA31-42E7-A408-BB1F5D610515Q26999804-CD3A48A1-0256-4BBB-8F6D-9B6A5D9BFB3DQ27000268-8C49BE0A-67C7-44F7-83AA-BB9B72E2AFDAQ27023122-8A3D1F02-4DC1-4CD2-B5FE-0C83EE0888C8Q30251763-62E716AC-8A01-41A0-8BEB-5C43804A295DQ33364276-8E70350D-F3C3-4296-B245-74D2A35B2A4FQ33983917-D5D3DCB6-55D1-49F6-9BE9-EC8574F10BC0Q33986493-E6565170-D482-4C4D-95FA-11BFEC274233Q34002050-0A51006B-2D98-430F-884A-D34806A33A1AQ34382061-2A102CA4-7745-4841-9593-892764A96C9FQ34475601-9CFB758C-D6A4-4711-B106-9355190EA3EBQ34523099-EAEB4EA7-9EF4-4303-A4A9-912FF9C5DCE1Q34533221-6CF8EBDB-77EA-4011-9E9D-3A03F498E1E2Q34597743-DBDF1A85-88E2-4AE3-9E86-AFBEAF358123Q34597754-752DD88D-0AF5-486C-BA8B-283DC164CFF8Q34600578-8B7B6CD3-6D93-4A3B-B593-50DACAE199A8Q34770385-E6AB8DBC-CE9B-475F-8A97-59B0A6075327Q35574320-96D4EE21-F05C-4CFC-B5C2-F3B6F42B30FBQ35654104-9577EB95-57B7-4FC4-AB2F-C72A1F947998Q35782626-2C1DCDD9-4082-4BF5-8F46-841942C8C04EQ35873829-3A88B307-CD74-4D6D-BDB4-40F91C7B5C6BQ35873832-BA749F01-7572-4B1A-A5FE-F23C7F81F3C9Q35873836-41E71AC0-9655-43C2-B16E-5BD14293ED34Q35873840-FE287F78-5783-48A4-9428-D7CC0D6AECBFQ35890613-72062312-8813-435C-A64A-1B41441259F8Q35919930-9911D560-74CF-4039-B08B-F8F371DCB0C1Q35994071-F90B52DA-1CB8-4DD5-87E5-8FBD1678C63AQ36014521-9807A89C-2A30-4FA0-BD1E-52F923D7757BQ36018527-79B5CBDC-6459-4B8C-8786-47BF63104CEEQ36090423-B2F12056-5671-42D2-9B83-6B2BE3957E2CQ36090748-015AEE0C-00F3-4407-81DE-3F31B69C1031Q36093575-8F19716B-83C7-4F5F-93E8-09B19C8F0AE8Q36146796-9BDFF6AE-0BE2-4383-9038-FEE44F548B2C
P2860
Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Terlipressin therapy with and ...... spective, nonrandomized study.
@ast
Terlipressin therapy with and ...... spective, nonrandomized study.
@en
type
label
Terlipressin therapy with and ...... spective, nonrandomized study.
@ast
Terlipressin therapy with and ...... spective, nonrandomized study.
@en
prefLabel
Terlipressin therapy with and ...... spective, nonrandomized study.
@ast
Terlipressin therapy with and ...... spective, nonrandomized study.
@en
P2093
P50
P356
P1433
P1476
Terlipressin therapy with and ...... ospective, nonrandomized study
@en
P2093
Blas Calahorra
Dara De Las Heras
Juan Rodés
Mónica Guevara
Ramón Bataller
Rolando Ortega
Wladimiro Jiménez
P304
P356
10.1053/JHEP.2002.35819
P407
P433
P577
2002-10-01T00:00:00Z